Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
Breakthrough in Brain Tumor Therapy Revolutionize Pediatric Care
A groundbreaking drug delivery approach has been developed by researchers at Mount Sinai Health System and Memorial Sloan Kettering Cancer Centre, offering new hope in the treatment of brain tumors in children. This innovative technique utilizes nanoparticles to deliver anti-cancer medications in a highly targeted and efficient manner....
Bristol Myers Launches Novel Drug for Treatment of Adults with Psoriasis
Bristol Myers Squibb has introduced Sotyktu (deucravacitinib), a groundbreaking selective tyrosine kinase 2 (TYK2) inhibitor, as a treatment option for adults with moderate-to-severe plaque psoriasis who are eligible for systemic therapy. ...
Breakthrough Vaccine for RSV Prevention in Older Adults
Pfizer has revealed that its vaccine candidate for respiratory syncytial virus (RSV), PF-06928316 or RSVpreF, has been granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration (FDA) for the prevention of lower respiratory tract disease associated with RSV in individuals aged 60 years and above....
Ractigen Therapeutics Introduces Novel Drug for ALS Treatment
Ractigen Therapeutics has unveiled RAG-17, an innovative siRNA modality designed to address Amyotrophic Lateral Sclerosis (ALS) treatment....
First-in-Disease Therapy for IgA Nephropathy by Everest Medicines
Everest Medicines has recently made an announcement regarding the approval of Nefecon, the pioneering treatment for primary immunoglobulin A nephropathy (IgAN), by the Hainan Medical Products Administration for clinical use....
HiST Pharma to Start Phase III Clinical Study to Treat Psoriasis Vulgaris
HiST Pharma, along with its wholly-owned Psoriasis Research Institute of Guangzhou (PRIG), made an announcement today regarding the approval from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) TC Cream....
FDA Approves Breakthrough Drug for GPP Flare Prevention
Spesolimab, a breakthrough medicine developed by Boehringer Ingelheim, shows promise in avoiding flares in individuals with generalized pustular psoriasis (GPP)....
SAB Biotherapeutics Investigational Influenza Therapeutic Launch
SAB Biotherapeutics has made an exciting announcement regarding their investigational therapeutic, SAB-176, which has received Breakthrough Therapy Designation (BTD) from the FDA....
Novel Drug Introduced by Genmab for R/R DLBCL Treatment
Genmab A/S has recently launched EPKINLY™ (epcoritamab-bysp), a groundbreaking drug designed for the treatment of relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL)....
Novel Non-immunosuppressive Therapy to Treat Kidney-Related Disease
A novel non-immunosuppressive therapy FILSPARI™ (sparsentan) has been granted approval by the U.S Food and Drug Administration to treat IgA nephropathy (IgAN). Oral sparsentan is recommended to reduce proteinuria (protein in the urine) in patients at risk for disease progression because it targets the endothelin-1 and angiotensin 2 pathways, both of which promote IgAN disease progression...
